Literature DB >> 10077670

The role of immunophilins in mutant superoxide dismutase-1linked familial amyotrophic lateral sclerosis.

J P Lee1, H C Palfrey, V P Bindokas, G D Ghadge, L Ma, R J Miller, R P Roos.   

Abstract

It has been reported that expression of familial amyotrophic lateral sclerosis (FALS)-associated mutant Cu/Zn superoxide dismutase-1 (SOD) induces apoptosis of neuronal cells in culture associated with an increase in reactive oxygen species. SOD recently has been shown to prevent calcineurin inactivation, initiating the present investigations examining the role of calcineurin in mutant SOD-induced cell death. Wild-type or mutant SOD was expressed in neuronal cells by infection with replication-deficient adenoviruses. PC12 cells overexpressing human wild-type SOD exhibited higher calcineurin activity than cells expressing FALS-related mutant SOD (SODV148G); however, cells expressing SODV148G had calcineurin activity equal to mock-infected cells, suggesting that cell death induced by mutant SOD was not related to a decrease in calcineurin activity. Calcineurin antagonists such as cyclosporin A and FK506, as well as nonimmunosuppressant analogs of cyclosporin A, significantly enhanced SODV148G- and SODA4V-induced cell death. Because both groups of drugs inhibit the rotamase activity of cyclophilins (CyP), but only the immunosuppressant analogs inhibit calcineurin activity, these data suggest that rotamase inhibition underlies the enhanced cell death after SODV148G expression. The importance of rotamase activity in mutant SOD-mediated apoptosis was supported by experiments showing that overexpressed wild-type cyclophilin A (CyPA), but not CyPA with a rotamase active site point mutation, protected cells from death after SODV148G expression. These data suggest that mutant SOD produces a greater need for rotamase and, also, highlights possible new therapeutic strategies in FALS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10077670      PMCID: PMC15928          DOI: 10.1073/pnas.96.6.3251

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Mitochondria - the Kraken wakes!

Authors:  R J Miller
Journal:  Trends Neurosci       Date:  1998-03       Impact factor: 13.837

2.  Dephosphorylation of cAMP-dependent protein kinase regulatory subunit (type II) by calmodulin-dependent protein phosphatase. Determinants of substrate specificity.

Authors:  D K Blumenthal; K Takio; R S Hansen; E G Krebs
Journal:  J Biol Chem       Date:  1986-06-25       Impact factor: 5.157

3.  Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein).

Authors:  J M McCord; I Fridovich
Journal:  J Biol Chem       Date:  1969-11-25       Impact factor: 5.157

4.  Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity.

Authors:  J Liu; M W Albers; T J Wandless; S Luan; D G Alberg; P J Belshaw; P Cohen; C MacKintosh; C B Klee; S L Schreiber
Journal:  Biochemistry       Date:  1992-04-28       Impact factor: 3.162

5.  Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity.

Authors:  D R Borchelt; M K Lee; H S Slunt; M Guarnieri; Z S Xu; P C Wong; R H Brown; D L Price; S S Sisodia; D W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

6.  Mitochondrial and glycolytic dysfunction in lethal injury to hepatocytes by t-butylhydroperoxide: protection by fructose, cyclosporin A and trifluoperazine.

Authors:  R Imberti; A L Nieminen; B Herman; J J Lemasters
Journal:  J Pharmacol Exp Ther       Date:  1993-04       Impact factor: 4.030

7.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

Authors:  D R Rosen; T Siddique; D Patterson; D A Figlewicz; P Sapp; A Hentati; D Donaldson; J Goto; J P O'Regan; H X Deng
Journal:  Nature       Date:  1993-03-04       Impact factor: 49.962

8.  Activity of some natural and modified (fluorescent) cyclosporins on T cells.

Authors:  M Koponen; F Loor
Journal:  Ann Immunol (Paris)       Date:  1983 Mar-Apr

9.  Inhibition of anoxia-induced injury in heart myocytes by cyclosporin A.

Authors:  W Nazareth; N Yafei; M Crompton
Journal:  J Mol Cell Cardiol       Date:  1991-12       Impact factor: 5.000

10.  Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog.

Authors:  B Rosenwirth; A Billich; R Datema; P Donatsch; F Hammerschmid; R Harrison; P Hiestand; H Jaksche; P Mayer; P Peichl
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

View more
  10 in total

1.  Differential loss of prolyl isomerase or chaperone activity of Ran-binding protein 2 (Ranbp2) unveils distinct physiological roles of its cyclophilin domain in proteostasis.

Authors:  Kyoung-in Cho; Hemangi Patil; Eugene Senda; Jessica Wang; Haiqing Yi; Sunny Qiu; Dosuk Yoon; Minzhong Yu; Andrew Orry; Neal S Peachey; Paulo A Ferreira
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

2.  Synaptic sprouting increases the uptake capacities of motoneurons in amyotrophic lateral sclerosis mice.

Authors:  S Millecamps; D Nicolle; I Ceballos-Picot; J Mallet; M Barkats
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

3.  Catalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A.

Authors:  Daryl A Bosco; Elan Z Eisenmesser; Susan Pochapsky; Wesley I Sundquist; Dorothee Kern
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

4.  Proteomics reveals novel oxidative and glycolytic mechanisms in type 1 diabetic patients' skin which are normalized by kidney-pancreas transplantation.

Authors:  Franco Folli; Valeria Guzzi; Lucia Perego; Dawn K Coletta; Giovanna Finzi; Claudia Placidi; Stefano La Rosa; Carlo Capella; Carlo Socci; Davide Lauro; Devjit Tripathy; Christopher Jenkinson; Rita Paroni; Elena Orsenigo; Giuliana Cighetti; Luisa Gregorini; Carlo Staudacher; Antonio Secchi; Angela Bachi; Michael Brownlee; Paolo Fiorina
Journal:  PLoS One       Date:  2010-03-29       Impact factor: 3.240

Review 5.  The involvement of mammalian and plant FK506-binding proteins (FKBPs) in development.

Authors:  Adina Breiman; Isabelle Camus
Journal:  Transgenic Res       Date:  2002-08       Impact factor: 2.788

Review 6.  The mitochondrial death pathway: a promising therapeutic target in diseases.

Authors:  Sanjeev Gupta; George E N Kass; Eva Szegezdi; Bertrand Joseph
Journal:  J Cell Mol Med       Date:  2009-02-09       Impact factor: 5.310

Review 7.  Cyclophilin A: a key player for human disease.

Authors:  P Nigro; G Pompilio; M C Capogrossi
Journal:  Cell Death Dis       Date:  2013-10-31       Impact factor: 8.469

8.  Heat shock factor 1 over-expression protects against exposure of hydrophobic residues on mutant SOD1 and early mortality in a mouse model of amyotrophic lateral sclerosis.

Authors:  Pei-Yi Lin; Sharotka M Simon; Won Kyun Koh; Oluwarotimi Folorunso; C Samuel Umbaugh; Anson Pierce
Journal:  Mol Neurodegener       Date:  2013-11-21       Impact factor: 14.195

9.  Time-Course of Metabolic and Proteomic Responses to Different Nitrate/Ammonium Availabilities in Roots and Leaves of Maize.

Authors:  Bhakti Prinsi; Luca Espen
Journal:  Int J Mol Sci       Date:  2018-07-27       Impact factor: 5.923

10.  Defective cyclophilin A induces TDP-43 proteinopathy: implications for amyotrophic lateral sclerosis and frontotemporal dementia.

Authors:  Laura Pasetto; Maurizio Grassano; Silvia Pozzi; Silvia Luotti; Eliana Sammali; Alice Migazzi; Manuela Basso; Giovanni Spagnolli; Emiliano Biasini; Edoardo Micotti; Milica Cerovic; Mirjana Carli; Gianluigi Forloni; Giovanni De Marco; Umberto Manera; Cristina Moglia; Gabriele Mora; Bryan J Traynor; Adriano Chiò; Andrea Calvo; Valentina Bonetto
Journal:  Brain       Date:  2021-12-31       Impact factor: 13.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.